Blood pressure lowering treatment for pre- venting stroke recurrence: a systematic review and meta-analysis. Int Arch Med. 2009;2:30. S9.4.3-3. PROGRESS Collaborative Group. Randomised trial of a perin- dopril-based blood-pressure-lowering regimen among 6 105 indi- viduals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033 41. S9.4.3-4. PATS Collaborating Group. Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J. 1995;108:710 7. S9.4.3-5. Lee M, Saver JL, Hong K-S, et al. Renin-angiotensin system modu- lators modestly reduce vascular risk in persons with prior stroke. Stroke. 2012;43:113 9. S9.4.3-6. Wang W-T, You L-K, Chiang C-E, et al. Comparative effectiveness of blood pressure-lowering drugs in patients who have already suf- fered from stroke: traditional and Bayesian network meta-analysis of randomized trials. Medicine (Baltimore). 2016;95:e3302. S9.4.3-7. Katsanos AH, Filippatou A, Manios E, et al. Blood pressure reduc- tion and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials. Hypertension. 2017;69:171 9. S9.4.3-8. Benavente OR, Coffey CS, Conwit R, et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. SPS3 Study Group. Lancet. 2013;382:507 15. S9.4.3-9. Arima H, Chalmers J, Woodward M, et al. Lower target blood pres- sures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006;24:1201 8. S9.4.3-10. Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics 2017 update: a report from the American Heart Association. Circulation. 2017;135:e146 603. S9.4.3-11. Dhamoon MS, Sciacca RR, Rundek T, et al. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology. 2006;66:641 6. S9.4.3-12. Hardie K, Hankey GJ, Jamrozik K, et al. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke. 2004;35:731 5. S9.4.3-13. Lovett JK, Coull AJ, Rothwell PM. 